Azafaros B.V. announced in January 2023 that it Investigational New Drug (IND) clearance from the United States Food and Drug Administration (FDA) to conduct a clinical Phase 2 trial for its lead asset, AZ-3102, for the treatment of GM2 gangliosidosis (GM2) and Niemann-Pick disease type C (NP-C). In addition to the IND clearance, the FDA …
Tag
Showing: 7 - 9 of 25 RESULTS
DART
DART To The Finish Charity Walk for NPC 2022 – Saturday * Sept. 24, 2022 * 8:00a
Gather your friends and family and join us for this year’s invigorating 2.0 mile walk around beautiful Tod’s Point in Old Greenwich, and help us raise much needed funds to find a cure for Niemann-Pick type C disease. No beach pass, no problem, DART has you covered. We’re expecting a wondrful in-person event, but if …